As crucial immune checkpoint molecules, T-cell inhibitory receptors, including CTLA-4, PD-1, TIM-3, LAG-3, and TIGIT, are essential in limiting immunopathology and terminating effective immune response, while they can also inhibit effective anti-tumor immunity (27). This evidence concerns the gene TIGIT and neoplasm.